Additionally, the concentrations of biochemical tumour markers including the carcinoembryonic antigen (CEA), carbohydrate antigen (CA19-9), and cancer antigen 72–4 (CA72-4) are crucial in the diagnosis of patients with this malignancy, but they cannot be utilised to identify GC early [8]. This evidence concerns the gene CEACAM5 and cancer.